198 related articles for article (PubMed ID: 32695826)
1. Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma.
Li Y; Deng G; Qi Y; Zhang H; Jiang H; Geng R; Ye Z; Liu B; Chen Q
Biomed Res Int; 2020; 2020():9716720. PubMed ID: 32695826
[TBL] [Abstract][Full Text] [Related]
2. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
[TBL] [Abstract][Full Text] [Related]
3. Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma.
Su X; Li H; Chen S; Qin C
Technol Cancer Res Treat; 2021; 20():15330338211010143. PubMed ID: 33896271
[TBL] [Abstract][Full Text] [Related]
4. Identification of Dysregulated microRNAs in Glioma Using RNA-sequencing.
Liu C; Ge YY; Xie XX; Luo B; Shen N; Liao XS; Bi SQ; Xu T; Xiao SW; Zhang QM
Curr Med Sci; 2021 Apr; 41(2):356-367. PubMed ID: 33877554
[TBL] [Abstract][Full Text] [Related]
5. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry.
Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J
Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924
[TBL] [Abstract][Full Text] [Related]
6. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
7. Expression of SREBP2 and cholesterol metabolism related genes in TCGA glioma cohorts.
Li D; Li S; Xue AZ; Smith Callahan LA; Liu Y
Medicine (Baltimore); 2020 Mar; 99(12):e18815. PubMed ID: 32195924
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
9. A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma.
Liu W; Zou J; Ren R; Liu J; Zhang G; Wang M
Technol Cancer Res Treat; 2021; 20():1533033821992084. PubMed ID: 33550903
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma.
Xiao H; Bai J; Yan M; Ji K; Tian W; Liu D; Ning T; Liu X; Zou J
World Neurosurg; 2019 Jun; 126():e765-e772. PubMed ID: 30853516
[TBL] [Abstract][Full Text] [Related]
11. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801
[TBL] [Abstract][Full Text] [Related]
12. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
Hao YP; Wang WY; Qiao Q; Li G
Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma.
Zhang Q; Liu XJ; Li Y; Ying XW; Chen L
Technol Cancer Res Treat; 2021; 20():15330338211011966. PubMed ID: 34159865
[TBL] [Abstract][Full Text] [Related]
14. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
15. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
16. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis.
Yang A; Wang X; Hu Y; Shang C; Hong Y
Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971
[TBL] [Abstract][Full Text] [Related]
17. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
[TBL] [Abstract][Full Text] [Related]
18. A prognostic signature of five pseudogenes for predicting lower-grade gliomas.
Liu B; Liu J; Liu K; Huang H; Li Y; Hu X; Wang K; Cao H; Cheng Q
Biomed Pharmacother; 2019 Sep; 117():109116. PubMed ID: 31247469
[TBL] [Abstract][Full Text] [Related]
19. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of PCDH9 expression by miR-215-5p up-regulation in gliomas.
Wang C; Chen Q; Li S; Li S; Zhao Z; Gao H; Wang X; Li B; Zhang W; Yuan Y; Ming L; He H; Tao B; Zhong J
Oncotarget; 2017 Feb; 8(6):10287-10297. PubMed ID: 28055966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
